News Column

Protea Biosciences Group, Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)] (Aug. 5, 2014)

August 18, 2014



By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Protea Biosciences Group, Inc. (Form 10-Q) was posted on August 5, 2014.

The SIC code for this company is 2834, Pharmaceutical Preparations.

There were 15 documents filed with this form. The SEC file number is 0001144204-14-047077.

The contact information for this company is 955 HARTMAN RUN ROAD, MORGANTOWN WV 26505, 304 292-2226.

Our editors provided additional information about Form 10-Q: The Form 10-Q is a report filed quarterly by most reporting companies. It includes unaudited financial statements and provides a continuing view of the company's financial position during the year. The report must be filed for each of the first three fiscal quarters of the company's fiscal year and is due within 45 days of the close of the quarter.

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1335103/0001144204-14-047077-index.html.

Keywords for this news article include: Pharmaceutical Preparations, Chemicals, Chemistry, SEC Filing, Biotechnology Company, Investment and Finance, Protea Biosciences Group Inc..

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Pharma Business Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters